Nefopam in primary care: How can it be used and under which conditions? (notice n° 516382)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 01147cam a2200217 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250121093628.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Frances, Pierre |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Nefopam in primary care: How can it be used and under which conditions? |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2022.<br/> |
500 ## - GENERAL NOTE | |
General note | 22 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Nefopam (Acupan®) is a centrally acting non-opioid analgesic used for the treatment of moderate to severe pain. Similar to a step one analgesic, according to the WHO pain ladder classification, it is a first- or second-line drug, depending on the intensity of the pain. However, due to a significant risk of drug dependence, it should not be used in the context of chronic pain. How can nefopam be used in primary care and under which conditions? |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gaubert, Robert |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gallaf, Widad |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Merikhi, Adam |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Noire, Marie Dorothée |
Relator term | author |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Philipon, Emma |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Médecine | 18 | 9 | 2022-11-01 | p. 395-397 | 1777-2044 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-medecine-2022-9-page-395?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-medecine-2022-9-page-395?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux